… for these PET biomarkers, … diseases that can lead to dementia. We propose three main
diagnostic pathways with distinct biomarker sequences, in which amyloid-PET and 18 F-FDG-PET …

… PET ligand and the image analysis method used. To address this problem quantifying amyloid
PET … in which to report quantitative amyloid PET values derived from different ligands and …

… The increasing use of amyloid PET in Alzheimer’s disease research and clinical trials has …
B (PiB) and that of two 18 F amyloid radiotracers (florbetapir and flutemetamol) using two study …

… This search resulted in twenty-nine papers on amyloid imaging, twenty-three papers on
FDG-PET … As evidenced from the current literature, both amyloid and FDG-PET meet criteria for …

… different amyloid PET ligands that are currently available are valid biomarkers for
Alzheimer-related β amyloidosis… , we will incorporate amyloid imaging into a multidimensional …

… pathway for Alzheimer’s disease (AD). PET using 18 F-labelled beta-amyloid PET tracers has
… diagnostic accuracy of the three beta-amyloid radiotracers. All tracers perform better when …

… presence of amyloid pathology in its earliest stages, but it plateaus relatively early in the
AD disease course, while amyloid PET imaging shows continued build-up of amyloid burden …

… the amyloid burden present in average mild to moderate severity dementia due to AD. This
important work allows for amyloid PET … with positive or negative amyloid PET scans based on …

… and amyloid PET for diagnosing early-stage Alzheimer disease (AD). … that amyloid PET and
CSF biomarkers identify early-stage AD equally accurately. Biomarkers of cerebral β-amyloid …

… -cerebral amyloid depositions. Finally, the potential use of amyloid PET tracer accumulation
… to a broader application of amyloid PET imaging in clinical practice beyond AD is provided. …